Drug Database
Back to search

Japan· JP-3999029M1029

フィンゴリモド塩酸塩

A fingolimod product containing フィンゴリモド塩酸塩, registered in Japan by 田辺ファーマ, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC L04AE01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフィンゴリモド塩酸塩ATCL04AE01REGISTER NO.JP-3999029M1029PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about フィンゴリモド塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fingolimod is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search fingolimod products by name

Fingolimod · ATC L04AE01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fingolimod costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fingolimod · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • IT Italy$27.25
  • CH Switzerland$18.53
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フィンゴリモド塩酸塩
Manufacturer
田辺ファーマ
Country
Japan (JP)
ATC code
L04AE01
ATC class
Fingolimod
Defined daily dose
0.5 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fingolimod against other medicinesHow interaction checks work

Fingolimod · interactions on record

584 records

  • 503 severe
  • 77 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AE01

Fingolimod, as other registers publish it.

All fingolimod products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f39b73f1-0d13-493d-bf2a-fa75d41b0947
GET /v1/drugs/f39b73f1-0d13-493d-bf2a-fa75d41b0947?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "０．５ｍｇ１カプセル",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3999029M1029",
  "category": "内用薬",
  "price_yen": 7513.1,
  "generic_name": "フィンゴリモド塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "3999",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console